Nonetheless, these data are consistent with studies linking increased NADPH oxidase activity/expression to obesity-induced oxidative stress and inflammation [32],[13],[33],[34]. The gene discussed is FMO5; the disease is obesity due to melanocortin 4 receptor deficiency.